189 related articles for article (PubMed ID: 34173857)
1. Activation of (un)regulated cell death as a new perspective for bispyridinium and imidazolium oximes.
Zandona A; Maraković N; Mišetić P; Madunić J; Miš K; Padovan J; Pirkmajer S; Katalinić M
Arch Toxicol; 2021 Aug; 95(8):2737-2754. PubMed ID: 34173857
[TBL] [Abstract][Full Text] [Related]
2. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice.
dos Santos AA; dos Santos DB; Ribeiro RP; Colle D; Peres KC; Hermes J; Barbosa AM; Dafré AL; de Bem AF; Kuca K; Farina M
Neurotoxicology; 2011 Dec; 32(6):888-95. PubMed ID: 21723318
[TBL] [Abstract][Full Text] [Related]
3. Antidotal treatment of GF-agent intoxication in mice with bispyridinium oximes.
Sevelová L; Kuca K; Krejcová-Kunesová G
Toxicology; 2005 Feb; 207(1):1-6. PubMed ID: 15590116
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of mono- and bis-pyridinium oximes versus soman, sarin and tabun poisoning in mice.
Clement JG
Fundam Appl Toxicol; 1983; 3(6):533-5. PubMed ID: 6662294
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity-related effects of imidazolium and chlorinated bispyridinium oximes in SH-SY5Y cells.
Zandona A; Zorbaz T; Miš K; Pirkmajer S; Katalinić M
Arh Hig Rada Toksikol; 2022 Dec; 73(4):277-284. PubMed ID: 36607726
[TBL] [Abstract][Full Text] [Related]
7. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
[TBL] [Abstract][Full Text] [Related]
8. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.
Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473
[TBL] [Abstract][Full Text] [Related]
9. In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication.
Arshad M; Fatmi MQ; Musilek K; Hussain A; Kuca K; Petroianu G; Kalasz H; Nurulain SM
Toxicol Mech Methods; 2018 Jan; 28(1):62-68. PubMed ID: 28722512
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in-vitro reactivation screening of imidazolium aldoximes as reactivators of sarin and VX-inhibited human acetylcholinesterase (hAChE).
Sharma R; Gupta B; Sahu AK; Acharya J; Satnami ML; Ghosh KK
Chem Biol Interact; 2016 Nov; 259(Pt B):85-92. PubMed ID: 27138243
[TBL] [Abstract][Full Text] [Related]
11. Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes.
Ekström FJ; Astot C; Pang YP
Clin Pharmacol Ther; 2007 Sep; 82(3):282-93. PubMed ID: 17443135
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the benefit of the bispyridinium compound MB327 for the antidotal treatment of nerve agent-poisoned mice.
Kassa J; Pohanka M; Timperley CM; Bird M; Green AC; Tattersall JE
Toxicol Mech Methods; 2016 Jun; 26(5):334-9. PubMed ID: 27097774
[TBL] [Abstract][Full Text] [Related]
13. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties.
Bhattacharjee AK; Kuca K; Musilek K; Gordon RK
Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase.
Winter M; Wille T; Musilek K; Kuca K; Thiermann H; Worek F
Toxicol Lett; 2016 Feb; 244():136-142. PubMed ID: 26210933
[TBL] [Abstract][Full Text] [Related]
15. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning.
Kovarik Z; Calić M; Sinko G; Bosak A; Berend S; Vrdoljak AL; Radić B
Chem Biol Interact; 2008 Sep; 175(1-3):173-9. PubMed ID: 18501341
[TBL] [Abstract][Full Text] [Related]
16. Biological response and cell death signaling pathways modulated by tetrahydroisoquinoline-based aldoximes in human cells.
Zandona A; Madunić J; Miš K; Maraković N; Dubois-Geoffroy P; Cavaco M; Mišetić P; Padovan J; Castanho M; Jean L; Renard PY; Pirkmajer S; Neves V; Katalinić M
Toxicology; 2023 Aug; 494():153588. PubMed ID: 37419273
[TBL] [Abstract][Full Text] [Related]
17. The 3,3'-bis-pyridinium mono-oximes as antidotes against organophosphorous intoxication.
Sikder AK; Pandey KS; Jaiswal DK; Dube SN; Kumar D; Husain K; Bhattacharya R; Das Gupta S
J Pharm Pharmacol; 1992 Dec; 44(12):1038-40. PubMed ID: 1361555
[TBL] [Abstract][Full Text] [Related]
18. Investigation of oxidative stress in blood, brain, kidney, and liver after oxime antidote HI-6 application in a mouse experimental model.
Pohanka M; Sobotka J; Svobodova H; Stetina R
Drug Chem Toxicol; 2011 Jul; 34(3):255-60. PubMed ID: 21649479
[TBL] [Abstract][Full Text] [Related]
19. Reactivation kinetics of a series of related bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase--Structure-activity relationships.
Worek F; Wille T; Koller M; Thiermann H
Biochem Pharmacol; 2012 Jun; 83(12):1700-6. PubMed ID: 22649796
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-activity relationships and possible mechanisms of action of bispyridinium oximes as antidotes against pinacolyl methylphosphonofluoridate.
Su CT; Tang CP; Ma C; Shih YS; Liu CY; Wu MT
Fundam Appl Toxicol; 1983; 3(4):271-7. PubMed ID: 6628889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
